El Harchi A - Search Results

1

COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2.

Carpenter A, Chambers OJ, El Harchi A, Bond R, Hanington O, Harmer SC, Hancox JC, James AF. Carpenter A, et al. Among authors: el harchi a. Front Cardiovasc Med. 2020 May 5;7:85. doi: 10.3389/fcvm.2020.00085. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 32432127 Free PMC article. Review.

2

The hERG potassium channel and hERG screening for drug-induced torsades de pointes.

Hancox JC, McPate MJ, El Harchi A, Zhang YH. Hancox JC, et al. Among authors: el harchi a. Pharmacol Ther. 2008 Aug;119(2):118-32. doi: 10.1016/j.pharmthera.2008.05.009. Epub 2008 Jun 18. Pharmacol Ther. 2008. PMID: 18616963 Review.

3

Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome.

El Harchi A, McPate MJ, Zhang Yh, Zhang H, Hancox JC. El Harchi A, et al. J Mol Cell Cardiol. 2009 Nov;47(5):743-7. doi: 10.1016/j.yjmcc.2009.02.027. Epub 2009 Mar 10. J Mol Cell Cardiol. 2009. PMID: 19285083 Free PMC article.

4

Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.

El Harchi A, McPate MJ, Zhang YH, Zhang H, Hancox JC. El Harchi A, et al. J Physiol Pharmacol. 2010 Apr;61(2):123-31. J Physiol Pharmacol. 2010. PMID: 20436212 Free article.

5

Acidosis impairs the protective role of hERG K(+) channels against premature stimulation.

Du CY, Adeniran I, Cheng H, Zhang YH, El Harchi A, McPate MJ, Zhang H, Orchard CH, Hancox JC. Du CY, et al. Among authors: el harchi a. J Cardiovasc Electrophysiol. 2010 Oct;21(10):1160-9. doi: 10.1111/j.1540-8167.2010.01772.x. J Cardiovasc Electrophysiol. 2010. PMID: 20455975

6

Enhanced inhibitory effect of acidosis on hERG potassium channels that incorporate the hERG1b isoform.

Du CY, El Harchi A, McPate MJ, Orchard CH, Hancox JC. Du CY, et al. Among authors: el harchi a. Biochem Biophys Res Commun. 2011 Feb 11;405(2):222-7. doi: 10.1016/j.bbrc.2011.01.014. Epub 2011 Jan 8. Biochem Biophys Res Commun. 2011. PMID: 21219869

7

The S140G KCNQ1 atrial fibrillation mutation affects 'I(KS)' profile during both atrial and ventricular action potentials.

El Harchi A, Zhang H, Hancox JC. El Harchi A, et al. J Physiol Pharmacol. 2010 Dec;61(6):759-64. J Physiol Pharmacol. 2010. PMID: 21224508 Free article.

8

Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis.

DU CY, El Harchi A, Zhang YH, Orchard CH, Hancox JC. DU CY, et al. Among authors: el harchi a. J Cardiovasc Electrophysiol. 2011 Oct;22(10):1163-70. doi: 10.1111/j.1540-8167.2011.02060.x. Epub 2011 Apr 13. J Cardiovasc Electrophysiol. 2011. PMID: 21489024

9

Molecular determinants of hERG potassium channel inhibition by disopyramide.

El Harchi A, Zhang YH, Hussein L, Dempsey CE, Hancox JC. El Harchi A, et al. J Mol Cell Cardiol. 2012 Jan;52(1):185-95. doi: 10.1016/j.yjmcc.2011.09.021. Epub 2011 Sep 29. J Mol Cell Cardiol. 2012. PMID: 21989164

10

Proarrhythmia in KCNJ2-linked short QT syndrome: insights from modelling.

Adeniran I, El Harchi A, Hancox JC, Zhang H. Adeniran I, et al. Among authors: el harchi a. Cardiovasc Res. 2012 Apr 1;94(1):66-76. doi: 10.1093/cvr/cvs082. Epub 2012 Feb 2. Cardiovasc Res. 2012. PMID: 22308236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters